Premium Nahrungsergänzungsmittel | artgerecht

Anticoagulants – Uses, Effects and Side Effects

Anticoagulants are medications that inhibit blood clotting and help prevent dangerous blood clots. They are used in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation.

Regular tips about health Regular tips about health

Things worth knowing about "Anticoagulants"

Anticoagulants are medications that inhibit blood clotting and help prevent dangerous blood clots. They are used in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation.

What Are Anticoagulants?

Anticoagulants are medications that slow down or inhibit the blood clotting process. They are commonly referred to as blood thinners, although they do not actually make the blood thinner or more fluid. Instead, they interfere with specific steps in the coagulation cascade to prevent the formation or growth of blood clots (thrombi).

When Are Anticoagulants Used?

Anticoagulants are prescribed to prevent the formation of blood clots or to stop existing clots from growing. Common indications include:

Deep vein thrombosis (DVT): Blood clots in the deep veins of the legs
Pulmonary embolism: Blockage of a pulmonary artery by a clot
Atrial fibrillation: A heart rhythm disorder associated with an increased risk of stroke
Mechanical heart valves: Increased clotting risk due to artificial materials
Stroke prevention: Reducing the risk of further events after an ischemic stroke
Post-surgical thromboprophylaxis: Prevention of clots after major surgery or prolonged immobility

Mechanism of Action

Blood clotting is a complex process involving multiple coagulation factors. Anticoagulants target different points within this cascade:

Vitamin K Antagonists (VKA)

Agents such as warfarin or phenprocoumon inhibit the synthesis of clotting factors that depend on vitamin K (factors II, VII, IX, and X). Their effect is delayed in onset and requires regular monitoring through the INR value (International Normalized Ratio).

Heparins

Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) such as enoxaparin or nadroparin enhance the activity of antithrombin, a natural inhibitor of coagulation. They are typically administered by subcutaneous injection or intravenously.

Direct Oral Anticoagulants (DOACs)

The newer class of direct oral anticoagulants (also called NOACs) selectively inhibit individual clotting factors:

Factor Xa inhibitors: Rivaroxaban, apixaban, edoxaban
Thrombin inhibitors (Factor IIa inhibitors): Dabigatran

These medications offer the advantage of fixed dosing and generally do not require routine coagulation monitoring.

Dosage and Administration

The dosing of anticoagulants depends on the indication, the individual risk profile of the patient, and the function of the kidneys and liver. Vitamin K antagonists require regular blood tests (INR monitoring) to guide dose adjustments. DOACs are typically taken at a fixed daily dose, although dose reduction may be necessary in patients with impaired kidney function.

Side Effects

The most significant risk associated with all anticoagulants is an increased tendency to bleed. Potential bleeding complications include:

Gastrointestinal bleeding
Intracranial hemorrhage (in rare cases)
Prolonged bleeding after injuries or surgical procedures
Easy bruising (hematomas) from minor trauma

With heparins, a rare but serious complication known as heparin-induced thrombocytopenia (HIT) can occur -- a paradoxical condition in which the risk of clotting is actually increased despite anticoagulant therapy.

Important Considerations and Interactions

Anticoagulants can interact with many other medications and foods. Key interactions include:

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin further increase bleeding risk.
Vitamin K-rich foods (e.g., spinach, kale) can reduce the effectiveness of vitamin K antagonists.
Certain antibiotics, antifungals, and other drugs may enhance or diminish anticoagulant effects.

Patients on anticoagulant therapy should always carry an anticoagulant card and inform all treating physicians and dentists about their medication.

References

Steffel J. et al. - The 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. European Heart Journal, 2021.
Kearon C. et al. - Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 2016.
Pschyrembel Clinical Dictionary. 268th Edition. De Gruyter, Berlin, 2020.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.